VivoSeq
Other

Children

0

Pipeline Programs↗

58

Active Trials↗

60

Companies Involved↗

Children is an early-stage landscape with 0 programs across 60 companies. The most active players are Pfizer, GSK, Sanofi.

Intelligence

Pipeline Metrics

Competitive Density

51/100

Pipeline Velocity

43/100

Mech. Concentration

N/A

Completion Rate

88/100

Attrition Rate

9/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Pfizer logo

Pfizer

0 programs

PreclinicalGSK logo

GSK

0 programs

PreclinicalSanofi logo

Sanofi

0 programs

PreclinicalMerck & Co. logo

Merck & Co.

0 programs

PreclinicalAstraZeneca logo

AstraZeneca

0 programs

PreclinicalBoehringer Ingelheim logo

Boehringer Ingelheim

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

575

clinical trials

Completed416 · 72%
Unknown status45 · 8%
Recruiting36 · 6%
Terminated33 · 6%
Withdrawn19 · 3%
Active, not recruiting13 · 2%
Other13 · 2%

Clinical Trials

Trial Activity

575 trials

Investigating the Pharmacokinetics of Tafenoquine in Healthy Papua New Guinean Children
Recruiting·—·Phase 4·NCT07052162·30 enrolled
Extended-release Sodium Oxybate in Children
Recruiting·SStanford University·Phase 2·NCT06809803·36 enrolled
CEUS for Blunt Abdominal Trauma in Children
Recruiting·—·Phase 4·NCT03490929·146 enrolled
Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD
Recruiting·Supernus Pharmaceuticals, Inc. logoSupernus Pharmaceuticals, Inc.·Phase 4·NCT04781140·286 enrolled
Efficacy of Striatin in Malnourished Children
Recruiting·UUniversitas Sriwijaya·Phase 3·NCT07089329·30 enrolled
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
Recruiting·—·N/A·NCT04278404·5,000 enrolled
Efficacy of INM004 in Children With STEC-HUS
Recruiting·—·Phase 3·NCT06389474·220 enrolled
Docosahexaenoic Acid on Breath Holding Spells in Children
Recruiting·—·Phase 3·NCT03965988·60 enrolled
Long Term Effect of AIT in Children
Recruiting·OOdense University Hospital·N/A·NCT06421415·100 enrolled
Triheptanoin for Children With Primary-Specific Pyruvate Dehydrogenase Complex (PDC) Deficiency
Recruiting·—·Phase 1·NCT06340685·6 enrolled
Pharmacokinetics of Drugs Administered to Children
Recruiting·—·N/A·NCT03481881·200 enrolled
A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
Recruiting·Pfizer logoPfizer·Phase 3·NCT06807281·500 enrolled
Determine Immunoglobulin G4 (IgG4) Standards for Cow's Milk and Egg in Different Populations of Allergic and Non-allergic Children
Recruiting·AAssistance Publique - Hôpitaux de Paris·N/A·NCT03776474·500 enrolled
Dose Individualization of Antineoplastic Drugs and Anti-Infective Drug in Children With Hematoplastic Disease
Recruiting·—·Phase 4·NCT03844360·1,500 enrolled
Role of Coenzyme Q in ADHD in Children
Recruiting·—·Phase 3·NCT04216186·40 enrolled
Page 1 of 39

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)